Showing 1891-1900 of 5631 results for "".
- EU Regulator Clears Manufacturing Sites to Boost COVID-19 Vaccine Supplyhttps://modernod.com/news/eu-regulator-clears-manufacturing-sites-to-boost-covid-19-vaccine-supply/2479025/The European Medicines Agency (EMA) said it adopted several actions aimed at boosting COVID-19 vaccine production and rollout in the EU. These include clearing the Halix production site in Leiden, the Netherlands that makes AstraZeneca’s vaccine AZD1222, as well as another facility located
- Pacific Vision Surgery Center Opens Doors to Bay Area Communityhttps://modernod.com/news/pacific-vision-surgery-center-opens-doors-to-bay-area-community/2478751/Pacific Vision Foundation has announced the opening of the new Pacific Vision Surgery Center. This state-of-the-art surgical facility is the manifestation of Pacific Vision Foundation’s mission to make excellent eye care available for all, regardless of ability to pay, while training the next gen
- Trump Administration Announces $5B COVID-19 Relief Funds, Future Testing Requirements for Nursing Homeshttps://modernod.com/news/trump-administration-announces-5b-covid-19-relief-funds-future-testing-requirements-for-nursing-homes/2478064/The Trump administration is allocating an additional $5 billion in COVID-19 relief funds to Medicare-certified long-term care facilities and state veteran nursing homes in hot spots where the virus is has begun spiking again, according to a FierceHealthcare
- BVI Donating Personal Protective Equipment to Help Protect the COVID-19 Frontlinehttps://modernod.com/news/bvi-donating-personal-protective-equipment-to-help-protect-the-covid-19-frontline/2477520/In a statement posted on its website, BVI stated that it is repurposing its products and redirecting supplies toward the COVID-19 response. It is also donating personal protective equipment (PPE) to health care facilities in hard hit areas. The statement reads: “COVID-19 is im
- Prevent Blindness Provides Free Eye Health Curriculum to Educators to Help Children Learn About Importance of Eye Carehttps://modernod.com/news/prevent-blindness-provides-free-eye-health-curriculum-to-educators-to-help-children-learn-about-importance-of-eye-care/2477518/Schools and educational facilities across the country are now closed due to the COVID-19 pandemic. Many educators, public health and non-profit groups are looking for quality, no-cost educational materials to support remote learning for children. Prevent Blindness is offering the
- Envision Research Institute Announces Search for Post Doctoral Fellows to Study Low Visionhttps://modernod.com/news/envision-research-institute-announces-search-for-post-doctoral-fellows-to-study-low-vision/2479664/The Gigi & Carl Allen Envision Research Institute (ERI) is now calling for letters of intent to apply for its next round of postdoctoral research fellowships. Launched in 2015 with a goal to restore function to those who are blind and visually impaired, the ERI provides access to funds, facil
- Coburn Technologies Announces New Location for Corporate Headquartershttps://modernod.com/news/coburn-technologies-announces-new-location-for-corporate-headquarters/2480113/Coburn Technologies announced the relocation of their corporate headquarters to a newly renovated, modern facility in South Windsor, Connecticut. Effective July 23, 2018, Coburn Technologies will operate from their new location – 83 Gerber Road West, South Windsor, Connecticut, 06074.
- Omidria Added to Veterans Health Administration National Formularyhttps://modernod.com/news/omidria-added-to-veterans-health-administration-national-formulary/2480248/Omeros announced that the Veterans Administration (VA) has added Omidria (phenylephrine and ketorolac intraocular solution 1% / 0.3%) to the VA National Formulary. The VA National Formulary is a listing of drugs and supplies that must be available at all VA facilities for the benefit of U.
- LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patientshttps://modernod.com/news/lumithera-provides-update-on-fda-review-of-valeda-treatment-for-dry-amd-patients/2482040/LumiThera announced an update on the regulatory status of the Valeda Light Delivery System. Following feedback from the FDA, a De Novo request to reclassify the Valeda Light Delivery System as a Class II device has been submitted for review. Under the De Novo request process, the V
- Aurion Announces Positive 12-Month Results from Phase 1/2 CLARA Trial of AURN001 Corneal Endothelial Cell Therapyhttps://modernod.com/news/aurion-announces-positive-12-month-results-from-phase-12-clara-trial-of-aurn001-corneal-endothelial-cell-therapy/2484196/Aurion Biotech announced positive 12-month results from its phase 1/2 CLARA clinical trial. The study evaluated the safety, efficacy, and tolerability of AURN001 (neltependocel [human corneal endothelial cells] in combination with Y-27632 rho-kinase inhibitor)